Skip to Content

Tavaborole use while Breastfeeding

Drugs containing Tavaborole: Kerydin

Medically reviewed by Drugs.com. Last updated on Jun 27, 2020.

Tavaborole Levels and Effects while Breastfeeding

Summary of Use during Lactation

Topical tavaborole has not been studied during breastfeeding. Because blood levels are very low after topical application to the toenails, it is unlikely that a measurable amount of the drug will enter the breastmilk.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Ciclopirox, Efinaconazole, Terbinafine

Substance Identification

Substance Name

Tavaborole

CAS Registry Number

174671-46-6

Drug Class

  • Breast Feeding
  • Lactation
  • Anti-Infective Agents
  • Antifungal Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.